Literature DB >> 5628200

[Ezperimental chemotherapy of Mycobacterium kansasi infection in the animal experiment].

B Burjanová, R Urbancík.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 5628200

Source DB:  PubMed          Journal:  Beitr Klin Erforsch Tuberk Lungenkr        ISSN： 0300-9696


× No keyword cloud information.
  8 in total

1.  [ANTIMYCOBACTERIAL ACTIVITY OF ISOXYL. STUDIES IN VITRO AND MICE].

Authors:  L TRNKA; R URBANCIK; H POLENSKA
Journal:  Pathol Microbiol (Basel)       Date:  1963

2.  Chromogenic acid-fast bacilli from human sources. IV. In vitro response to a number of antimicrobial agents on glycerol-blood agar medium.

Authors:  M S TARSHIS; W A WEED; M V PARKER; W B DUNHAM
Journal:  Am Rev Tuberc       Date:  1955-07

3.  Susceptibility in vitro of unclassified mycobacteria to commonly used antimicrobials.

Authors:  L R GUY; J S CHAPMAN
Journal:  Am Rev Respir Dis       Date:  1961-11

4.  Drug sensitivities of atypical acid-fast organisms.

Authors:  S VIRTANEN
Journal:  Acta Tuberc Scand       Date:  1961

5.  Chemotherapy of diseases caused by atypical mycobacteria. I. In vitro response to a number of antimicrobiol agents in blood agar, 7H9 and Loewenstein media.

Authors:  R URBANCIK
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1959

6.  Drug susceptibilities of 20 atypical as compared with 19 selected strains of mycobacteria.

Authors:  E WOLINSKY; M M SMITH; W STEENKEN
Journal:  Am Rev Tuberc       Date:  1957-09

7.  [Atypical mycobacteria as pathogens in humans].

Authors:  G Meissner
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1965

8.  [Experimental treatment of "atypical" mycobacterial infections].

Authors:  E Freerksen
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1965
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.